{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:48:23Z","timestamp":1789048103957,"version":"build-2803163510"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>A record number of Opioid-related deaths occurred in Northern Ireland in 2021 and it is acknowledged that the Covid-19 pandemic compounded drugs related deaths crisis. This co-production study set out to refine the design of a wearable device for Opioid users to detect and subsequently prevent a potential overdose situation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Purposive sampling was used to recruit people who had substance use disorders and were living in a hostel and prison during the Covid-19 pandemic. Principles of co-production influenced the study, which encompassed a focus group phase and a wearable phase. The initial phase included three focus groups with participants who inject Opioids and one focus group with workers from a street injector support service. During the wearable phase, the participant group tested the feasibility of the wearable technology in a controlled environment. This included testing the transferability of data from the device to a backend server on the cloud.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>All focus group participants expressed an interest in the wearable technology when it was presented to them and agreed, that in principle, such a device would be extremely beneficial to help reduce the risk of overdose within the active drug using community. Participants outlined factors which would help or hinder the design of this proposed device and their decision to wear it, if it were readily available to them. Findings from wearable phase indicated that it was feasible to use a wearable device for monitoring Opioid users\u2019 biomarkers remotely. The provision of information regarding the specific functionality of the device was considered key and could be disseminated via front line services. The data acquisition and transfer process would not be a barrier for future research.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Understanding the benefit and disadvantages of technologies such as a wearable device to prevent Opioid-related deaths will be critical for mitigating the risk of overdose for people who use Heroin. It was also clear that this would be particularly relevant during Covid-19 lock-down periods, when the effects of the pandemic further exacerbated the isolation and solitude experienced by people who use Heroin.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2023.1080629","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T05:27:04Z","timestamp":1686806824000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Reducing opioid related deaths for individuals who are at high risk of death from overdose: a co-production study with people housed within prison and hostel accommodation during Covid-19"],"prefix":"10.3389","volume":"11","author":[{"given":"Anne","family":"Campbell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Millen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uisce","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Taylor-Beswick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Rintoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisling","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,15]]},"reference":[{"key":"ref1","volume-title":"Statistics press notice \u2013 Drug-related and drug misuse deaths registered in Northern Ireland (2010\u20132020)","year":"2022"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-021-00522-3","article-title":"Willingness to use a wearable device capable of detecting and reversing overdose among people who use heroin in Philadelphia","volume":"18","author":"Kanter","year":"2021","journal-title":"Harm Reduct J"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e2125538","DOI":"10.1001\/jamanetworkopen.2021.25538","article-title":"Comparison of characteristics of deaths from drug overdose before vs during the COVID-19 pandemic in Rhode Island","volume":"4","author":"Macmadu","year":"2021","journal-title":"JAMA Netw Open"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/s41591-020-0898-0","article-title":"An overdose surge will compound the COVID-19 pandemic if urgent action is not taken","volume":"26","author":"Wakeman","year":"2020","journal-title":"Nat Med"},{"key":"ref5","volume-title":"Drug deaths in NI: A new poly drug use trajectory involving opioids, Research Benzos and Gabapentin","author":"Campbell","year":"2023"},{"key":"ref6","volume-title":"The unequal pandemic: COVID-19 and health inequalities","author":"Bambra","year":"2021"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"103554","DOI":"10.1016\/j.drugpo.2021.103554","article-title":"The COVID-19 pandemic and the health of people who use illicit heroin in new York City, the first 12 months","volume":"101","author":"Bennett","year":"2022","journal-title":"Int J Drug Policy"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"103391","DOI":"10.1016\/j.drugpo.2021.103391","article-title":"Living under coronavirus and injecting drugs in Bristol (LUCID-B): a qualitative study of experiences of COVID-19 among people who inject drugs","volume":"98","author":"Kesten","year":"2021","journal-title":"Int J Drug Policy"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1111\/j.1360-0443.2010.02990.x","article-title":"Meta-analysis of drug-related deaths soon after release from prison","volume":"105","author":"Merrall","year":"2010","journal-title":"Addiction"},{"key":"ref10","volume-title":"World drug report 2021","year":"2021"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drugpo.2017.05.017","article-title":"The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland","volume":"46","author":"O\u2019Halloran","year":"2017","journal-title":"Int J Drug Policy"},{"key":"ref12","volume-title":"The UK drugs review, Phase One Report","author":"Black","year":"2020"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1109\/GLOBECOM38437.2019.9014293","article-title":"Wearable eHealth system for physical rehabilitation: ankle plantar-dorsi-flexion monitoring","volume":"2019","author":"Domingues","year":"2019","journal-title":"IEEE Glob Commun Conf (GLOBECOM)"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1177\/1049732318798358","article-title":"Wandering as a sociomaterial practice: extending the theorization of GPS tracking in cognitive impairment","volume":"29","author":"Wherton","year":"2019","journal-title":"Qual Health Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41746-022-00664-z","article-title":"Impact of individual and treatment characteristics on wearable sensor-based digital biomarkers of opioid use","volume":"5","author":"Chapman","year":"2022","journal-title":"NPJ Dig Medi"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.schres.2014.03.021","article-title":"Online, social media and mobile technologies for psychosis treatment: a systematic review on novel user-led interventions","volume":"156","author":"Alvarez-Jimenez","year":"2014","journal-title":"Schizophr Res"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1109\/JBHI.2014.2360711","article-title":"Complexity index from a personalized wearable monitoring system for assessing remission in mental health","volume":"19","author":"Lanata","year":"2015","journal-title":"IEEE J Biomed Health Inform"},{"key":"ref18","article-title":"Overdose alert and response technologies (ODART): a state-of-the-art review","author":"Oteo","year":"2022"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/dar.13645","article-title":"A scoping review of mHealth technologies for Opioid overdose prevention, detection and response","volume":"42","author":"Tas","year":"2022","journal-title":"Drug Alcohol Rev"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e3077","DOI":"10.2196\/jmir.3077","article-title":"The behavioral intervention technology model: an integrated conceptual and technological framework for eHealth and mHealth interventions","volume":"16","author":"Mohr","year":"2014","journal-title":"J Med Internet Res"},{"key":"ref21","first-page":"13","article-title":"Theoretical models to inform technology-based health behavior interventions","volume-title":"Behavioral healthcare and technology: Using science-based innovations to transform practice","author":"Riley","year":"2015"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1037\/prj0000246","article-title":"Health behavior models for informing digital technology interventions for individuals with mental illness","volume":"40","author":"Naslund","year":"2017","journal-title":"Psychiatr Rehabil J"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s13142-015-0324-1","article-title":"Building new computational models to support health behavior change and maintenance: new opportunities in behavioral research","volume":"5","author":"Spruijt-Metz","year":"2015","journal-title":"Transl Behav Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e25583","DOI":"10.1002\/jia2.25583","article-title":"Challenges posed by COVID-19 to people who inject drugs and lessons from other outbreaks","volume":"23","author":"Vasylyeva","year":"2020","journal-title":"J Int AIDS Soc"},{"key":"ref25","volume-title":"Co-production","year":"2018"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/systems8040052","article-title":"How we understand \u201ccomplexity\u201d makes a difference: lessons from critical systems thinking and the Covid-19 pandemic in the UK","volume":"8","author":"Jackson","year":"2020","journal-title":"Systems"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/09581596.2021.1909707","article-title":"COVID-19 contact tracing apps: UK public perceptions","volume":"32","author":"Samuel","year":"2022","journal-title":"Crit Public Health"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"pgac096","DOI":"10.1093\/pnasnexus\/pgac096","article-title":"Modeling pandemic to endemic patterns of SARS-CoV-2 transmission using parameters estimated from animal model data","volume":"1","author":"Mullin","year":"2022","journal-title":"PNAS Nexus"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1001\/jamapsychiatry.2020.4218","article-title":"Overdose-related cardiac arrests observed by emergency medical services during the US COVID-19 epidemic","volume":"78","author":"Friedman","year":"2021","journal-title":"JAMA Psychiat"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1080629\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T13:14:45Z","timestamp":1687180485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1080629\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,15]]},"references-count":29,"alternative-id":["10.3389\/fpubh.2023.1080629"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1080629","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,15]]},"article-number":"1080629"}}